@profmq
Account based inUnited Kingdom
About this account
- Account based in
- United Kingdom
- Connected via
- Web
Account-level information from X, not a live location or the device used for a specific post.
Professor of Law, Medicine, & Technology University of Birmingham @bhamlaw. Also tweeting @EverydayCyborgs.
Birmingham, England
Joined June 2016
- Tweets4.6K
- Following748
- Followers1.1K
- Likes2.5K
Pinned Tweet
New paper out by myself, @LauraJDowney, @zaina_mahmoud94, & @JeanMcHale2. Setting out where we are with medical devices regulation in the UK, how we got here, & where we might be going.
In latest issue @profmq @LauraJDowney @zaina_mahmoud94 and Jean McHale analyse the complex situation regarding the regulation of #MedicalDevices in the UK #innovation #PatientSafety @EverydayCyborgs
🔗doi.org/10.5204/lthj.3102
ALT The Shape of Medical Devices Regulation in the United Kingdom? Brexit and Beyond
Later today, presenting some work on psychedelics. Based on a chapter I have written with Dr Matt Hayler (English Lit @ UoB)
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Muireann Quigley retweeted
@PatentsInHumans Prof Aisling McMahon & Dr Opeyemi Kolawole article just out #MedicalLawReview on 'Biobank Donation in search of public benefits & Potential impact of IPRs over access to health technologies developed: A focus on bioethical implications' academic.oup.com/medlaw/adva…
Muireann Quigley retweeted
Developing Esketamine (Spravato) and Lessons for Psychedelic Drug Developers with Jaskaran Singh
psychedelicalpha.com/news/de…
Muireann Quigley retweeted
Really excited to see this published today in @MedLawInt - my latest article considering the construction of the best interests of women with a SMI in the obstetric context and the untapped potential of advance decisions.
Muireann Quigley retweeted
ICER Draft Evidence Report on Lykos’ MDMA-Assisted Psychotherapy Deems Clinical Evidence “Insufficient”
psychedelicalpha.com/news/ic…
Muireann Quigley retweeted
MindMed becomes the fourth organisation to receive such FDA Breakthrough Therapy Designation for a psychedelic drug candidate.
Previously, MAPS, Compass Pathways and Usona Institute received the designation, for MDMA and psilocybin (x2), respectively.
MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
finance.yahoo.com/news/mindm…
Muireann Quigley retweeted
FDA Hands MindMed's LSD Candidate Breakthrough Therapy Designation in Generalised Anxiety Disorder; Company Provides 12-Week Data and Fleshes Out Phase 3 Program Plans
Our coverage:
psychedelicalpha.com/news/fd…
Muireann Quigley retweeted
Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in Psilocybin-Related Poison Centre Calls
psychedelicalpha.com/news/p%…
Muireann Quigley retweeted
Colorado’s Draft Natural Medicine Rules: A High-Level Overview
The first draft rules for CO's regulated psychedelics market were revealed on Feb 16th.
The folks at Vicente LLP have parsed through the 39-page draft rules to provide a concise overview.
psychedelicalpha.com/news/co…
Muireann Quigley retweeted
Emma Cave @profEmmaCave @DurhamLawSchool @durham_uni discusses how the sufficiency of young adults’ autonomy is judged in light of biological, social and psychological evidence that #adolescence can continue into the mid 20s faculti.net/skeleton-keys-to… #law #medicallaw
Muireann Quigley retweeted
A brief thread about a new paper by me on neurotech & human rights. Right at the time when #Neuralink reports its first in-human brain-computer interface implant (which is btw not the first brain implant, but a new device implanted through a new method)../
tandfonline.com/doi/full/10.…
Muireann Quigley retweeted
We are looking for two new associate editors! Pls RT and get in touch if you have any questions ✨
Muireann Quigley retweeted
Bullseye Chart: The Psychedelic Drug Development Pipeline
@MichaelHaichin and @NoahJSmith98 have produced the latest iteration of our psychedelic drug dev. bullseye chart.
Access and download the full-size chart here:
psychedelicalpha.com/news/th…
Muireann Quigley retweeted
Good news - today is NOT the last day to submit an abstract to this unmissable event! There's another couple of weeks to do so!
@ilagalasso @SErikainen @PickersgillM
Don't forget to submit abstract - extended deadline 19 Feb!
We'll examine design, delivery & implications of 'targeted' biomedicine & public health to help better understand dynamics between science, healthcare & society
More info misfires.ucd.ie/events-news/
Venue @UCDQuinnSchool
Muireann Quigley retweeted
Interview: Compass Pathways $CMPS CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and Competitive Landscape
psychedelicalpha.com/news/in…
So much yes to all of this. Relevant not just for privacy law scholarship, but all of it!
This is probably the most useful piece of privacy law Scholarship I ever read. Recommended to junior (or perhaps senior) colleagues..
ojs.library.queensu.ca/index…
Muireann Quigley retweeted
Over the weekend, the first Home Office-licensed, local government-commissioned, fully funded, regular drug testing service launched in Bristol city centre. This finally marks the end of the pilot stage of drug testing facilities. ✊ Read in thread 🧵
Muireann Quigley retweeted
Medical Law International is recruiting two new associate editors to join our team (alongside the new co-EICs @israblack @alex_mullock @ECRomanis & Sarah Devaney) information below 👇 Pls share widely and get in touch if you want to discuss!
